PATH MER Indicators, published by PATH. This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/PATH-Global-Health/MERindicators and changes regularly. See the Directory of published versions
Draft as of 2023-10-19 |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:CodeSystem ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "DAKICD11"] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-insensitive code system <code>http://hl7.org/fhir/sid/icd-11</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">1C62.0<a name=\"DAKICD11-1C62.460\"> </a></td><td>HIV disease clinical stage 1 without mention of tuberculosis or malaria</td></tr><tr><td style=\"white-space:nowrap\">1C62.1<a name=\"DAKICD11-1C62.461\"> </a></td><td>HIV disease clinical stage 2 without mention of tuberculosis or malaria</td></tr><tr><td style=\"white-space:nowrap\">1C62.2<a name=\"DAKICD11-1C62.462\"> </a></td><td>HIV disease clinical stage 3 without mention of tuberculosis or malaria</td></tr><tr><td style=\"white-space:nowrap\">1C62.3<a name=\"DAKICD11-1C62.463\"> </a></td><td>HIV disease clinical stage 4 without mention of tuberculosis or malaria</td></tr><tr><td style=\"white-space:nowrap\">1C62.Z<a name=\"DAKICD11-1C62.46Z\"> </a></td><td>Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified</td></tr><tr><td style=\"white-space:nowrap\">XM63K0<a name=\"DAKICD11-XM63K0\"> </a></td><td>Anti-infective antiviral</td></tr><tr><td style=\"white-space:nowrap\">QA14<a name=\"DAKICD11-QA14\"> </a></td><td>Contact with health services for human immunodeficiency virus counselling</td></tr><tr><td style=\"white-space:nowrap\">XM35P4<a name=\"DAKICD11-XM35P4\"> </a></td><td>Abacavir</td></tr><tr><td style=\"white-space:nowrap\">XM2L06<a name=\"DAKICD11-XM2L06\"> </a></td><td>Emtricitabine</td></tr><tr><td style=\"white-space:nowrap\">XM5471<a name=\"DAKICD11-XM5471\"> </a></td><td>Lamivudine</td></tr><tr><td style=\"white-space:nowrap\">XM9C07<a name=\"DAKICD11-XM9C07\"> </a></td><td>Zidovudine</td></tr><tr><td style=\"white-space:nowrap\">XM8Z78<a name=\"DAKICD11-XM8Z78\"> </a></td><td>Didanosine</td></tr><tr><td style=\"white-space:nowrap\">XM7RM1<a name=\"DAKICD11-XM7RM1\"> </a></td><td>Stavudine</td></tr><tr><td style=\"white-space:nowrap\">XM67N3<a name=\"DAKICD11-XM67N3\"> </a></td><td>Tenofovir disoproxil</td></tr><tr><td style=\"white-space:nowrap\">XM1DX2<a name=\"DAKICD11-XM1DX2\"> </a></td><td>Efavirenz</td></tr><tr><td style=\"white-space:nowrap\">XM7N44<a name=\"DAKICD11-XM7N44\"> </a></td><td>Etravirine</td></tr><tr><td style=\"white-space:nowrap\">XM10T5<a name=\"DAKICD11-XM10T5\"> </a></td><td>Nevirapine</td></tr><tr><td style=\"white-space:nowrap\">XM1KD4<a name=\"DAKICD11-XM1KD4\"> </a></td><td>Rilpivirine</td></tr><tr><td style=\"white-space:nowrap\">XM4TF3<a name=\"DAKICD11-XM4TF3\"> </a></td><td>Atazanavir and Ritonavir</td></tr><tr><td style=\"white-space:nowrap\">XM3EH7<a name=\"DAKICD11-XM3EH7\"> </a></td><td>Lopinavir and Ritonavir</td></tr><tr><td style=\"white-space:nowrap\">XM8ZN1<a name=\"DAKICD11-XM8ZN1\"> </a></td><td>Darunavir and Ritonavir</td></tr><tr><td style=\"white-space:nowrap\">XM56L1<a name=\"DAKICD11-XM56L1\"> </a></td><td>Ritonavir</td></tr><tr><td style=\"white-space:nowrap\">XM6K45<a name=\"DAKICD11-XM6K45\"> </a></td><td>Dolutegravir</td></tr><tr><td style=\"white-space:nowrap\">XM82D3<a name=\"DAKICD11-XM82D3\"> </a></td><td>Raltegravir</td></tr><tr><td style=\"white-space:nowrap\">XM8QY9<a name=\"DAKICD11-XM8QY9\"> </a></td><td>Lamivudine, Tenofovir disoproxil and Dolutegravir</td></tr><tr><td style=\"white-space:nowrap\">XM3U67<a name=\"DAKICD11-XM3U67\"> </a></td><td>Antivirals for treatment of human immunodeficiency virus infections, combinations best fit</td></tr><tr><td style=\"white-space:nowrap\">XM9NL2<a name=\"DAKICD11-XM9NL2\"> </a></td><td>Lamivudine, Tenofovir disoproxil and Efavirenz</td></tr><tr><td style=\"white-space:nowrap\">XM2UU9<a name=\"DAKICD11-XM2UU9\"> </a></td><td>Lamivudine, Abacavir and Dolutegravir</td></tr></table></div>"
] ; #
fhir:url [ fhir:v "http://hl7.org/fhir/sid/icd-11"^^xsd:anyURI] ; #
fhir:version [ fhir:v "0.1.0"] ; #
fhir:name [ fhir:v "DAKICD11"] ; #
fhir:title [ fhir:v "ICD-11 codes from the HIV DAK"] ; #
fhir:status [ fhir:v "draft"] ; #
fhir:experimental [ fhir:v "false"^^xsd:boolean] ; #
fhir:date [ fhir:v "2023-10-19T20:59:19+00:00"^^xsd:dateTime] ; #
fhir:publisher [ fhir:v "PATH"] ; #
fhir:contact ( [
fhir:name [ fhir:v "PATH" ] ;
( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://www.path.org" ] ] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "info@path.org" ] ] )
] [
fhir:name [ fhir:v "PATH" ] ;
( fhir:telecom [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "info@path.org" ] ;
fhir:use [ fhir:v "work" ] ] )
] ) ; #
fhir:description [ fhir:v "ICD-11 codes from the HIV DAK"] ; #
fhir:jurisdiction ( [
( fhir:coding [
fhir:system [ fhir:v "http://unstats.un.org/unsd/methods/m49/m49.htm"^^xsd:anyURI ] ;
fhir:code [ fhir:v "001" ] ;
fhir:display [ fhir:v "World" ] ] )
] ) ; #
fhir:caseSensitive [ fhir:v "false"^^xsd:boolean] ; #
fhir:content [ fhir:v "complete"] ; #
fhir:count [ fhir:v "28"^^xsd:nonNegativeInteger] ; #
fhir:concept ( [
fhir:code [ fhir:v "1C62.0" ] ;
fhir:display [ fhir:v "HIV disease clinical stage 1 without mention of tuberculosis or malaria" ]
] [
fhir:code [ fhir:v "1C62.1" ] ;
fhir:display [ fhir:v "HIV disease clinical stage 2 without mention of tuberculosis or malaria" ]
] [
fhir:code [ fhir:v "1C62.2" ] ;
fhir:display [ fhir:v "HIV disease clinical stage 3 without mention of tuberculosis or malaria" ]
] [
fhir:code [ fhir:v "1C62.3" ] ;
fhir:display [ fhir:v "HIV disease clinical stage 4 without mention of tuberculosis or malaria" ]
] [
fhir:code [ fhir:v "1C62.Z" ] ;
fhir:display [ fhir:v "Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified" ]
] [
fhir:code [ fhir:v "XM63K0" ] ;
fhir:display [ fhir:v "Anti-infective antiviral" ]
] [
fhir:code [ fhir:v "QA14" ] ;
fhir:display [ fhir:v "Contact with health services for human immunodeficiency virus counselling" ]
] [
fhir:code [ fhir:v "XM35P4" ] ;
fhir:display [ fhir:v "Abacavir" ]
] [
fhir:code [ fhir:v "XM2L06" ] ;
fhir:display [ fhir:v "Emtricitabine" ]
] [
fhir:code [ fhir:v "XM5471" ] ;
fhir:display [ fhir:v "Lamivudine" ]
] [
fhir:code [ fhir:v "XM9C07" ] ;
fhir:display [ fhir:v "Zidovudine" ]
] [
fhir:code [ fhir:v "XM8Z78" ] ;
fhir:display [ fhir:v "Didanosine" ]
] [
fhir:code [ fhir:v "XM7RM1" ] ;
fhir:display [ fhir:v "Stavudine" ]
] [
fhir:code [ fhir:v "XM67N3" ] ;
fhir:display [ fhir:v "Tenofovir disoproxil" ]
] [
fhir:code [ fhir:v "XM1DX2" ] ;
fhir:display [ fhir:v "Efavirenz" ]
] [
fhir:code [ fhir:v "XM7N44" ] ;
fhir:display [ fhir:v "Etravirine" ]
] [
fhir:code [ fhir:v "XM10T5" ] ;
fhir:display [ fhir:v "Nevirapine" ]
] [
fhir:code [ fhir:v "XM1KD4" ] ;
fhir:display [ fhir:v "Rilpivirine" ]
] [
fhir:code [ fhir:v "XM4TF3" ] ;
fhir:display [ fhir:v "Atazanavir and Ritonavir" ]
] [
fhir:code [ fhir:v "XM3EH7" ] ;
fhir:display [ fhir:v "Lopinavir and Ritonavir" ]
] [
fhir:code [ fhir:v "XM8ZN1" ] ;
fhir:display [ fhir:v "Darunavir and Ritonavir" ]
] [
fhir:code [ fhir:v "XM56L1" ] ;
fhir:display [ fhir:v "Ritonavir" ]
] [
fhir:code [ fhir:v "XM6K45" ] ;
fhir:display [ fhir:v "Dolutegravir" ]
] [
fhir:code [ fhir:v "XM82D3" ] ;
fhir:display [ fhir:v "Raltegravir" ]
] [
fhir:code [ fhir:v "XM8QY9" ] ;
fhir:display [ fhir:v "Lamivudine, Tenofovir disoproxil and Dolutegravir" ]
] [
fhir:code [ fhir:v "XM3U67" ] ;
fhir:display [ fhir:v "Antivirals for treatment of human immunodeficiency virus infections, combinations best fit" ]
] [
fhir:code [ fhir:v "XM9NL2" ] ;
fhir:display [ fhir:v "Lamivudine, Tenofovir disoproxil and Efavirenz" ]
] [
fhir:code [ fhir:v "XM2UU9" ] ;
fhir:display [ fhir:v "Lamivudine, Abacavir and Dolutegravir" ]
] ) . #
IG © 2023+ PATH. Package path.merindicators#0.1.0 based on FHIR 4.0.1. Generated 2023-10-19
Links: Table of Contents |
QA Report |
Version History |
|